234 related articles for article (PubMed ID: 1901563)
1. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man.
Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
Gut; 1991 Mar; 32(3):275-7. PubMed ID: 1901563
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study.
Bours MJ; Bos HJ; Meddings JB; Brummer RJ; van den Brandt PA; Dagnelie PC
BMC Gastroenterol; 2007 Jun; 7():23. PubMed ID: 17578566
[TBL] [Abstract][Full Text] [Related]
3. Glucose and citrate reduce the permeability changes caused by indomethacin in humans.
Bjarnason I; Smethurst P; Macpherson A; Walker F; McElnay JC; Passmore AP; Menzies IS
Gastroenterology; 1992 May; 102(5):1546-50. PubMed ID: 1568563
[TBL] [Abstract][Full Text] [Related]
4. Local effect of adenosine 5'-triphosphate on indomethacin-induced permeability changes in the human small intestine.
Bours MJ; Troost FJ; Brummer RJ; Bast A; Dagnelie PC
Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):245-50. PubMed ID: 17301652
[TBL] [Abstract][Full Text] [Related]
5. The effect of polyacrylic acid polymers on small-intestinal function and permeability changes caused by indomethacin.
Bjarnason I; Smethurst P; Levi AJ; Menzies IS; Peters TJ
Scand J Gastroenterol; 1991 Jul; 26(7):685-8. PubMed ID: 1896808
[TBL] [Abstract][Full Text] [Related]
6. Effect of prostaglandin on indomethacin-induced increased intestinal permeability in man.
Bjarnason I; Smethurst P; Clark P; Menzies I; Levi J; Peters T
Scand J Gastroenterol Suppl; 1989; 164():97-102; discussion 102-3. PubMed ID: 2510288
[TBL] [Abstract][Full Text] [Related]
7. Misoprostol reduces indomethacin-induced changes in human small intestinal permeability.
Bjarnason I; Smethurst P; Fenn CG; Lee CE; Menzies IS; Levi AJ
Dig Dis Sci; 1989 Mar; 34(3):407-11. PubMed ID: 2493366
[TBL] [Abstract][Full Text] [Related]
8. Small bowel permeability--a variable effect of NSAIDS.
Choi VM; Coates JE; Chooi J; Thomson AB; Russell AS
Clin Invest Med; 1995 Oct; 18(5):357-61. PubMed ID: 8529318
[TBL] [Abstract][Full Text] [Related]
9. Intestinal permeability and inflammation in patients on NSAIDs.
Sigthorsson G; Tibble J; Hayllar J; Menzies I; Macpherson A; Moots R; Scott D; Gumpel MJ; Bjarnason I
Gut; 1998 Oct; 43(4):506-11. PubMed ID: 9824578
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs and renal response to exercise: a comparison of indomethacin and nabumetone.
Olsen NV; Jensen NG; Hansen JM; Christensen NJ; Fogh-Andersen N; Kanstrup IL
Clin Sci (Lond); 1999 Oct; 97(4):457-65. PubMed ID: 10491346
[TBL] [Abstract][Full Text] [Related]
11. Effect of non-steroidal anti-inflammatory drugs on the human small intestine.
Bjarnason I; Zanelli G; Prouse P; Williams P; Gumpel MJ; Levi AJ
Drugs; 1986; 32 Suppl 1():35-41. PubMed ID: 3780475
[TBL] [Abstract][Full Text] [Related]
12. Effects of nonsteroidal antiinflammatory drugs on permeability of the small intestine in humans.
Bjarnason I; Fehilly B; Smethurst P; Menzies IS; Levi AJ
J Rheumatol Suppl; 1992 Nov; 36():83-4. PubMed ID: 1474542
[No Abstract] [Full Text] [Related]
13. Role of bile in pathogenesis of indomethacin-induced enteropathy.
Jacob M; Foster R; Sigthorsson G; Simpson R; Bjarnason I
Arch Toxicol; 2007 Apr; 81(4):291-8. PubMed ID: 17151867
[TBL] [Abstract][Full Text] [Related]
14. Influence of anti-rheumatic drugs on gut permeability and on the gut associated lymphoid tissue.
Bjarnason I; Peters TJ
Baillieres Clin Rheumatol; 1996 Feb; 10(1):165-76. PubMed ID: 8674146
[TBL] [Abstract][Full Text] [Related]
15. Antiinflammatory drug-induced small intestinal permeability: the rat is a suitable model.
Davies NM; Wright MR; Jamali F
Pharm Res; 1994 Nov; 11(11):1652-6. PubMed ID: 7870685
[TBL] [Abstract][Full Text] [Related]
16. The effect of nabumetone and its principal active metabolite on in vitro human gastric mucosal prostanoid synthesis and platelet function.
Jeremy JY; Mikhailidis DP; Barradas MA; Kirk RM; Dandona P
Br J Rheumatol; 1990 Apr; 29(2):116-9. PubMed ID: 2108782
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of nabumetone with indomethacin on rat gastric mucosal 6-keto-PGF1 alpha production and on bile salt-induced changes in gastric mucosal function.
Melarange R; Rashbrook LC
J Pharm Pharmacol; 1987 Sep; 39(9):717-20. PubMed ID: 2445949
[TBL] [Abstract][Full Text] [Related]
18. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.
Bjarnason I; Williams P; Smethurst P; Peters TJ; Levi AJ
Gut; 1986 Nov; 27(11):1292-7. PubMed ID: 3466837
[TBL] [Abstract][Full Text] [Related]
19. Effect of the antiinflammatory prodrug, nabumetone and its principal active metabolite on rat gastric mucosal, aortic and platelet eicosanoid synthesis, in vitro and ex vivo.
Jeremy JY; Thompson CS; Mikhailidis DP; Dandona P
Prostaglandins Leukot Essent Fatty Acids; 1990 Nov; 41(3):195-9. PubMed ID: 2281122
[TBL] [Abstract][Full Text] [Related]
20. Effects of nabumetone, a new non-steroidal anti-inflammatory drug, on urinary prostaglandin excretion in man.
Giannessi D; Lazzerini G; Filipponi P; Mannarelli C; Vaiani G; Grossi E; De Caterina R
Pharmacol Res; 1993; 28(3):229-41. PubMed ID: 8108313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
